Navigation Links
Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:6/3/2010

ABBOTT PARK, Ill., June 3 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) scientists and independent researchers will highlight the latest clinical trial data on four of Abbott's investigational oncology compounds at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled for June 4-8 in Chicago. The presentations include data on inhibitors of VEGFR and PDGFR, PARP and bcl-2, and a humanized monoclonal antibody directed against CS1. Abbott's oncology pipeline currently includes nine new molecular entities in the clinic, targeting more than 15 different cancers and tumor types.

Meeting abstracts are available online at www.asco.org.

"With more than 12 million cancer patients diagnosed globally each year, we are fighting one of the greatest battles in medicine," said John Leonard, M.D., senior vice president, pharmaceuticals, research and development, Abbott. "The varied nature of the disease requires a diverse approach that includes multiple disease targets in different tumor types, and this is exactly the development path that we have chosen."

Presentation Highlights

Abbott's oncology pipeline consists of several different approaches for a broad range
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
2. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
3. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
4. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
5. Assegai Wins Big Settlement Against ABBOTTs Subsidiary
6. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
7. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
8. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
9. Abbott Completes Acquisition of Facet Biotech
10. Abbott Completes Acquisition of STARLIMS Technologies
11. Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- In a sweeping analysis assessing the current state of ... researchers conclude that there remains considerable room for improving ... groups, but especially for adolescents and young adults. The ... underscoring the need to address barriers to care and ... 1 patients achieve optimal metabolic control. ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
(Date:5/21/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced that on ... company,s vice president of operations, was granted an option to ... per share exercise price of $0.43, the closing trading price ... to Cardica, Inc.,s Inducement Plan, which was approved by the ... of the Nasdaq Global Market for equity grants to induce ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Cardica Announces New Employment Inducement Grant 2
... DURECT Corporation,(Nasdaq: DRRX ) announced today ... accepted the New Drug Application (NDA) of REMOXY(R) ... Review to drug,candidates that have the potential to ... goal for completing review of a drug,with Priority ...
... Receive Milestone Payment from MedImmune, PRINCETON, N.J., ... announced today that its partner MedImmune, Inc. has,initiated ... for the,potential treatment of systemic lupus erythematosus (SLE ... by Medarex,s UltiMAb Human,Antibody Development System(R). Under the ...
Cached Medicine Technology:REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 4
(Date:5/22/2015)... WA (PRWEB) May 22, 2015 According to ... of all generations are equally as likely to worry about ... Millennials, 75% Gen X, 77% Boomers, 69% Silent Generation), which ... agree they are scared of aging, particularly Millennials (47%), Gen ... by Harris Poll in April, 2015 among more than 2,000 ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The ... Plaza Dental announces that they are now offering ... and other dental treatments. At consultations, patients can ... Questions regarding what certain treatments can achieve and ... covered during this initial appointment. If treatments are ...
(Date:5/22/2015)... 2015 Wimbledon Health Partners, the leading ... echocardiogram and NCV testing , is proud to ... All American National athlete, to the Wimbledon Athletics division. ... high level of testing and information it provides to ... athletic trainers, this way they can focus on the ...
(Date:5/22/2015)... Houston, Texas (PRWEB) May 22, 2015 ... Denver, Colorado. In the past 9 years they have ... across the United States and Canada. Because of this ... they have established corporate offices in Denver, Colorado, Cleveland, ... Veatch Consulting specializes in opening new dental offices, dental ...
(Date:5/22/2015)... 2015 In efforts to offer full ... containing particular muscles stretches has been a large focus ... stretches now complete, Chunk Fitness envisions a mid-June launch ... filmed and released at a later point in time. ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness ...
Breaking Medicine News(10 mins):Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3
... 15, 2009 Avalon Laboratories, LLC (Avalon) today announced it ... Administration (FDA) and CE Mark acceptance from the European Union ... systems. The clearances enable Avalon to begin distributing these products ... and the European Union. The company also was issued ...
... a leading,innovator of physiological monitoring solutions, has been ... 2009 award for the Onyx(R) II, Model 9560,fingertip ... oximeter,the innovative device combines Bluetooth(R) wireless technology with ... accurately,monitor vital signs. , ...
... Heartland Dental Care, Inc.,acquired four dental practices and ... 2008. , The four ... in Springfield, Va., and two practices in McKinney, ... include locations in,Hendersonville, Tenn., Sycamore, Ill., and Liberty ...
... homes, seniors increasingly turning to home care vs. assisted ... estate crisis has affected all aspects of life, and ... unable to sell their homes, moving to an assisted ... reason, the option of aging-in-place with retrofits is growing ...
... policy and government relations firms to provide integrated services ... WashingtonWASHINGTON, Jan. 15 EBG Advisors, Inc. and Oldaker ... Advisors, LLC, a strategic alliance of the public policy ... care law firms, and a leading government relations firm. ...
... may lead to blood clots, study says , , THURSDAY, ... pills don,t seem to increase the risk of heart disease ... , But more research on the newer generations of ... especially true because more women over age 35 are taking ...
Cached Medicine News:Health News:Avalon Laboratories receives FDA and European clearances to market three catheter devices 2Health News:Nonin Medical's Onyx(R) II, Model 9560 Receives Bluetooth SIG's Best of CES 2009 Award 2Health News:Heartland Dental Care, Inc. Adds Seven Dental Practices in Fourth Quarter 2008 2Health News:Housing Crisis Affects Seniors Needing Care 2Health News:Housing Crisis Affects Seniors Needing Care 3Health News:EBG Advisors and Oldaker Group Form National Health Advisors 2Health News:Newer Contraceptives Don't Increase Heart Risk 2Health News:Newer Contraceptives Don't Increase Heart Risk 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: